"Novel Antivirals Target Cell Structures to Combat Cold Sores Effectively"

New research shows that PIN1 inhibitors can effectively combat Herpes simplex virus outbreaks, offering hope for a more efficient antiviral drug targeting cold sores.

• PIN1 inhibitors are a novel class of antiviral drug that could significantly reduce outbreaks of Herpes simplex virus 1, which causes cold sores.
• The virus responsible for oral herpes, Herpes simplex virus, remains in the body post-infection and can reactivate, affecting 50% to 90% of the global population.
• The study, published in Antiviral Research, highlights the role of enzyme inhibitors in disrupting DNA replication processes of the virus to prevent blister formation.